Download PDF
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2017; 04(03): 147-154
DOI: 10.4103/jnacc-jnacc-36.16
Original Article
Thieme Medical and Scientific Publishers Private Ltd.

Assessment of the role of gabapentin in patients with supratentorial tumours undergoing craniotomy under general anaesthesia: A double-blind randomised study

Rabie Soliman
1   Department of Anaesthesia, Faculty of Medicine, Cairo University, Giza, Egypt
,
Gomaa Zohry
1   Department of Anaesthesia, Faculty of Medicine, Cairo University, Giza, Egypt
› Author Affiliations
Further Information

Publication History

Publication Date:
08 May 2018 (online)

   Permissions and Reprints

Abstract

Background: Gabapentin attenuates the haemodynamics, decreases the catecholamine release and has a neuroprotective effect. The aim of the present study was to assess the effect of gabapentin in patients with supratentorial brain tumours undergoing craniotomy under general anaesthesia. Methods: A radial arterial line, central venous line and ventriculostomy catheters were inserted before surgery. Anaesthesia was induced with thiopental, fentanyl and atracurium and maintained with sevoflurane, fentanyl and atracurium infusion. The study included 160 patients classified randomly into two groups: Group G: The patients received gabapentin capsules 1200 mg orally 2 h before surgery. Group C: The patients received placebo capsules. Results: The heart rate, mean arterial blood pressure and intracranial pressure decreased significantly with gabapentin as compared to the control group (P < 0.05). The dose of fentanyl and end-tidal sevoflurane was lower with gabapentin than the control group (P < 0.05). The urine output was higher in the gabapentin group than the control group (P < 0.05). The Glasgow coma scale score was better in the gabapentin group as compared to the control group (P < 0.05). The incidence of nausea and vomiting was lower in the gabapentin group as compared to the control group (P < 0.05). Conclusions: Pre-operative administration of gabapentin in patients undergoing craniotomy under general anaesthesia minimised the fluctuations in haemodynamics, reduced the requirements for sevoflurane and fentanyl, decreased intracranial pressure and improved the outcomes. There were some side effects associated with gabapentin such as hypotension and bradycardia.

Keywords

Gabapentin - Glasgow coma scale score - haemodynamics - intracranial pressure - supratentorial craniotomy
 

  • REFERENCES

  • 1 Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology 2000; 93: 48-54
    CrossrefPubMedGoogle Scholar
  • 2 Gibson BE, Black S, Maass L, Cucchiara RF. Esmolol for the control of hypertension after neurologic surgery. Clin Pharmacol Ther 1988; 44: 650-3
    CrossrefPubMedGoogle Scholar
  • 3 Muzzi DA, Black S, Losasso TJ, Cucchiara RF. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg 1990; 70: 68-71
    CrossrefPubMedGoogle Scholar
  • 4 Su TZ, Lunney E, Campbell G, Oxender DL. Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: A comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem 1995; 64: 2125-31
    PubMedGoogle Scholar
  • 5 Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB. et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000; 20: 467-71
    CrossrefPubMedGoogle Scholar
  • 6 Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2 delta subunit of a calcium channel. J Biol Chem 1996; 271: 5768-76
    CrossrefPubMedGoogle Scholar
  • 7 Fassoulaki A, Melemeni A, Paraskeva A, Petropoulos G. Gabapentin attenuates the pressor response to direct laryngoscopy and tracheal intubation. Br J Anaesth 2006; 96: 769-73
    CrossrefPubMedGoogle Scholar
  • 8 Memis D, Turan A, Karamanlioglu B, Seker S, Türe M. Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. Eur J Anaesthesiol 2006; 23: 686-90
    CrossrefPubMedGoogle Scholar
  • 9 Kong VK, Irwin MG. Gabapentin: A multimodal perioperative drug?. Br J Anaesth 2007; 99: 775-86
    CrossrefPubMedGoogle Scholar
  • 10 Singhal SK, Kaur K, Arora P. Oral clonidine versus gabapentin as premedicant for obtunding hemodynamic response to laryngoscopy and tracheal intubation. Saudi J Anaesth 2014; 8: 172-7
    CrossrefPubMedGoogle Scholar
  • 11 Bharti N, Bala I, Narayan V, Singh G. Effect of gabapentin pretreatment on propofol consumption, hemodynamic variables, and postoperative pain relief in breast cancer surgery. Acta Anaesthesiol Taiwan 2013; 51: 10-3
    CrossrefPubMedGoogle Scholar
  • 12 Bafna U, Goyal VK, Garg A. A comparison of different doses of gabapentin to attenuate the haemodynamic response to laryngoscopy and tracheal intubation in normotensive patients. J Anaesthesiol Clin Pharmacol 2011; 27: 43-6
    PubMedGoogle Scholar
  • 13 Todd RD, McDavid SM, Brindley RL, Jewell ML, Currie KP. Gabapentin inhibits catecholamine release from adrenal chromaffin cells. Anesthesiology 2012; 116: 1013-24
    CrossrefPubMedGoogle Scholar
  • 14 Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP. et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998; 29: 233-49
    CrossrefPubMedGoogle Scholar
  • 15 Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J. et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997; 324: 153-60
    CrossrefPubMedGoogle Scholar
  • 16 Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG. et al. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berl) 1996; 127: 1-9
    CrossrefPubMedGoogle Scholar
  • 17 Calabresi P, Cupini LM, Centonze D, Pisani F, Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 2003; 53: 693-702
    CrossrefPubMedGoogle Scholar
  • 18 Khan ZH, Rahimi M, Makarem J, Khan RH. Optimal dose of pre-incision/post-incision gabapentin for pain relief following lumbar laminectomy: A randomized study. Acta Anaesthesiol Scand 2011; 55: 306-12
    CrossrefPubMedGoogle Scholar
  • 19 Ménigaux C, Adam F, Guignard B, Sessler DI, Chauvin M. Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg 2005; 100: 1394-9
    CrossrefPubMedGoogle Scholar
  • 20 Doha NM, Rady A, El Azab SR. Preoperative use of gabapentin decreases the anesthetic and analgesic requirements in patients undergoing radical mastectomy. Egypt J Anesth 2010; 26: 287-91
    PubMedGoogle Scholar
  • 21 Türe H, Sayin M, Karlikaya G, Bingol CA, Aykac B, Türe U. The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: A prospective randomized study. Anesth Analg 2009; 109: 1625-31
    CrossrefPubMedGoogle Scholar
  • 22 Misra S, Koshy T, Unnikrishnan KP, Suneel PR, Chatterjee N. Gabapentin premedication decreases the hemodynamic response to skull pin insertion in patients undergoing craniotomy. J Neurosurg Anesthesiol 2011; 23: 110-7
    CrossrefPubMedGoogle Scholar
  • 23 Ali AR, El Gohary IM, Ashmawi HS, El-Kerdawy HM, Essa HH. Efficacy of preoperative oral gabapentin in attenuation of neuro-endocrine response to laryngoscopy and endotracheal intubation. J Med Sci 2009; 9: 24-9
    CrossrefPubMedGoogle Scholar
  • 24 El Bakry AA, Hatim M. The effect of gabapentin premedication on pain and anxiety during cataract surgery under peribulbar block. Egypt J Anaesth 2012; 28: 43-7
    PubMedGoogle Scholar
  • 25 Maneuf YP, Gonzalez MI, Sutton KS, Chung FZ, Pinnock RD, Lee K. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol Life Sci 2003; 60: 742-50
    CrossrefPubMedGoogle Scholar
  • 26 Sarantopoulos C, McCallum B, Kwok WM, Hogan Q. Gabapentin decreases membrane calcium currents in injured as well as in control mammalian primary afferent neurons. Reg Anesth Pain Med 2002; 27: 47-57
    PubMedGoogle Scholar
  • 27 Pandey CK, Sahay S, Gupta D, Ambesh SP, Singh RB, Raza M. et al. Preemptive gabapentin decreases postoperative pain after lumbar discoidectomy. Can J Anaesth 2004; 51: 986-9
    CrossrefPubMedGoogle Scholar
  • 28 Seib RK, Paul JE. Preoperative gabapentin for postoperative analgesia: A meta-analysis. Can J Anaesth 2006; 53: 461-9
    CrossrefPubMedGoogle Scholar
  • 29 Prabhakar H, Arora R, Bithal PK, Rath GP, Dash HH. The analgesic effects of preemptive gabapentin in patients undergoing surgery for brachial plexus injury – A preliminary study. J Neurosurg Anesthesiol 2007; 19: 235-8
    CrossrefPubMedGoogle Scholar
  • 30 Misra S, Parthasarathi G, Vilanilam GC. The effect of gabapentin premedication on postoperative nausea, vomiting, and pain in patients on preoperative dexamethasone undergoing craniotomy for intracranial tumors. J Neurosurg Anesthesiol 2013; 25: 386-91
    CrossrefPubMedGoogle Scholar
  • 31 Guttuso Jr. T, Roscoe J, Griggs J. Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer. Lancet 2003; 361: 1703-5
    CrossrefPubMedGoogle Scholar
  • 32 Pandey CK, Priye S, Ambesh SP, Singh S, Singh U, Singh PK. Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled study. J Postgrad Med 2006; 52: 97-100
    PubMedGoogle Scholar
  • 33 Omran AF, Mohamed AE. A randomized study of the effects of gabapentin versus placebo on post-thoracotomy pain and pulmonary function. Egypt J Anaesth 2005; 21: 277-81
    PubMedGoogle Scholar
  • 34 Pandey CK, Priye S, Singh S, Singh U, Singh RB, Singh PK. Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy. Can J Anaesth 2004; 51: 358-63
    CrossrefPubMedGoogle Scholar
  • 35 Pandey CK, Navkar DV, Giri PJ, Raza M, Behari S, Singh RB. et al. Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: A randomized, double-blind, placebo-controlled study. J Neurosurg Anesthesiol 2005; 17: 65-8
    CrossrefPubMedGoogle Scholar
  • 36 Elazzazi H, Atalla R. Evaluation of the optimum preemptive dose of gabapentin and its postoperative morphine-sparing effect after debridement of burned patient. Ain Shams J Anaesthesiol 2014; 7: 138-42
    PubMedGoogle Scholar
  • 37 Rekling JC. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett 2003; 335: 167-70
    CrossrefPubMedGoogle Scholar
  • 38 Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995; 65: 643-51
    PubMedGoogle Scholar
  • 39 Pang CY, Neligan P, Xu H, He W, Zhong A, Hopper R. et al. Role of ATP-sensitive K+channels in ischemic preconditioning of skeletal muscle against infarction. Am J Physiol 1997; 273 (1 Pt 2) H44-51
    PubMedGoogle Scholar
  • 40 Lagrèze WA, Müller-Velten R, Feuerstein TJ. The neuroprotective properties of gabapentin-lactam. Graefes Arch Clin Exp Ophthalmol 2001; 239: 845-9
    CrossrefPubMedGoogle Scholar
  • 41 Lauritzen I, De Weille JR, Lazdunski M. The potassium channel opener(–)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J Neurochem 1997; 69: 1570-9
    CrossrefPubMedGoogle Scholar
  • 42 Boll MC, Alcaraz-Zubeldia M, Montes S, Rios C. Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO (x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 2008; 33: 1717-23
    CrossrefPubMedGoogle Scholar
  • 43 Baydas G, Sonkaya E, Tuzcu M, Yasar A, Donder E. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats. Acta Pharmacol Sin 2005; 26: 417-22
    CrossrefPubMedGoogle Scholar
  • 44 Williams AJ, Bautista CC, Chen RW, Dave JR, Lu XC, Tortella FC. et al. Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. J Pharmacol Exp Ther 2006; 318: 947-55
    CrossrefPubMedGoogle Scholar
  • 45 Lunn TH, Husted H, Laursen MB, Hansen LT, Kehlet H. Analgesic and sedative effects of perioperative gabapentin in total knee arthroplasty: A randomized, double-blind, placebo-controlled dose-finding study. Pain 2015; 156: 2438-48
    CrossrefPubMedGoogle Scholar
  • 46 Lo HS, Yang CM, Lo HG, Lee CY, Ting H, Tzang BS. Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol 2010; 33: 84-90
    CrossrefPubMedGoogle Scholar
  • 47 Peng PW, Wijeysundera DN, Li CC. Use of gabapentin for perioperative pain control – A meta-analysis. Pain Res Manag 2007; 12: 85-92
    PubMedGoogle Scholar
  • 48 Chavant F, Favrelière S, Lafay-Chebassier C, Plazanet C, Pérault-Pochat MC. Memory disorders associated with consumption of drugs: Updating through a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol 2011; 72: 898-904
    CrossrefPubMedGoogle Scholar